Cleerly Raises $106M in Series C Extension Funding Led by Insight Partners

Cleerly, a leader in advanced cardiovascular imaging, has announced the successful closure of its Series C extension funding round, securing a total of $106 million. Insight Partners, a global software investor, led this funding round, with participation from Battery Ventures and pre-existing investors. The company plans to utilize the funding to expand commercial reach and support clinical evidence generation.

Cleerly aims to improve patient outcomes in coronary care using FDA-cleared solutions powered by artificial intelligence. Its non-invasive computed tomography (CT) imaging technology enables comprehensive phenotyping of coronary artery disease based on extensive scientific research. With its mission to eliminate heart attacks, Cleerly is focused on driving a new standard of care for heart disease through FDA-cleared solutions leveraging artificial intelligence.

Insight Partners, the global software investor leading the Series C extension funding round for Cleerly, is dedicated to partnering with high-growth technology, software, and Internet startup and ScaleUp companies, aiming to drive transformative change in their respective industries. As of June 30, 2024, the firm possesses over $80 billion in regulatory assets under management and has a successful track record of investing in numerous companies worldwide.